30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Sonoma Pharmaceuticals Inc (SNOA)

Track

The most recent insider trading activity occurred on January 3, 2025, with a proposed sale of 86,111 shares valued at $232,499.70 by 10% Stockholder Gottfurcht Grant. Prior to this, on January 2 and December 31, 2024, Gottfurcht Grant also engaged in proposed sales. Earlier transactions in August 2024 also involved proposed sales by this insider.
Stock chart
Ticker: SNOA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gottfurcht Grant
10% Stockholder
1 sale — total 232,500 USD
Proposed sale 3 Jan 2025
Value US$802,259.09 | Price 163.36 | Shares 46,799
Proposed sale 2 Jan 2025
Value US$464,985.80 | Price 354.57 | Shares 78,129
Proposed sale 2 Jan 2025
Value US$3,326,821.46 | Price 454.08 | Shares 13,398
Proposed sale 31 Dec 2024
Value US$48,562.46 | Price 2.73 | Shares 17,806
Proposed sale 31 Dec 2024
Value US$48,562.46 | Price 2.73 | Shares 17,806
Proposed sale 9 Aug 2024
Value US$56,457.00 | Price 0.26 | Shares 221,375
Buy 13 Mar 2018
Value US$4,919.52 | Price 4.10 | Shares 1,200
Buy 12 Mar 2018
Value US$4,836.00 | Price 4.03 | Shares 1,200
Buy 12 Mar 2018
Value US$4,836.00 | Price 4.03 | Shares 1,200
Buy 9 Mar 2018
Value US$4,680.00 | Price 3.90 | Shares 1,200
Buy 8 Mar 2018
Value US$9,867.27 | Price 3.99 | Shares 2,473
Buy 30 Nov 2017
Value US$1,707.75 | Price 4.95 | Shares 345
Buy 29 Nov 2017
Value US$6,475.80 | Price 5.02 | Shares 1,290
Buy 29 Nov 2017
Value US$2,515.00 | Price 5.03 | Shares 500
Buy 29 Nov 2017
Value US$2,012.00 | Price 5.03 | Shares 400
Buy 24 Nov 2017
Value US$1,282.70 | Price 5.05 | Shares 254
Buy 21 Nov 2017
Value US$2,520.00 | Price 5.04 | Shares 500
Buy 21 Nov 2017
Value US$7,545.00 | Price 5.03 | Shares 1,500
Buy 10 Aug 2017
Value US$11,999.20 | Price 5.30 | Shares 2,264
Buy 10 Aug 2017
Value US$3,186.00 | Price 5.31 | Shares 600
Buy 10 Aug 2017
Value US$5,069.46 | Price 5.46 | Shares 929
Buy 9 Mar 2017
Value US$1,785.00 | Price 7.14 | Shares 250
Buy 9 Mar 2017
Value US$1,740.00 | Price 6.96 | Shares 250
Buy 9 Mar 2017
Value US$1,742.50 | Price 6.97 | Shares 250
Buy 8 Mar 2017
Value US$5,227.50 | Price 6.97 | Shares 750
Buy 8 Mar 2017
Value US$1,702.50 | Price 6.81 | Shares 250
Buy 6 Mar 2017
Value US$5,115.00 | Price 6.82 | Shares 750
Buy 3 Mar 2017
Value US$702.00 | Price 6.75 | Shares 104
Buy 3 Mar 2017
Value US$4,718.88 | Price 6.78 | Shares 696
Buy 8 Dec 2016
Value US$24,300.00 | Price 4.86 | Shares 5,000
Buy 8 Dec 2016
Value US$4,880.00 | Price 4.88 | Shares 1,000
Buy 15 Aug 2016
Value US$4,865.66 | Price 3.66 | Shares 1,328
Buy 25 Feb 2016
Value US$4,999.50 | Price 1.00 | Shares 5,000
Buy 17 Nov 2014
Value US$11,187.30 | Price 1.78 | Shares 6,285
Buy 16 Aug 2013
Value US$11,985.00 | Price 2.35 | Shares 5,100
Buy 10 Dec 2012
Value US$1,598.25 | Price 0.64 | Shares 2,500
Buy 10 Dec 2012
Value US$1,909.20 | Price 0.64 | Shares 3,000
Buy 7 Dec 2012
Value US$65.00 | Price 0.65 | Shares 100
Buy 7 Dec 2012
Value US$1,427.58 | Price 0.65 | Shares 2,200
Buy 7 Dec 2012
Value US$1,295.20 | Price 0.65 | Shares 2,000
Buy 7 Dec 2012
Value US$650.00 | Price 0.65 | Shares 1,000
Buy 6 Dec 2012
Value US$2,549.20 | Price 0.64 | Shares 4,000
Buy 6 Dec 2012
Value US$1,898.70 | Price 0.63 | Shares 3,000
Buy 6 Dec 2012
Value US$629.20 | Price 0.63 | Shares 1,000
Buy 6 Dec 2012
Value US$625.60 | Price 0.63 | Shares 1,000
Buy 9 Nov 2012
Value US$780.00 | Price 0.78 | Shares 1,000
Buy 9 Nov 2012
Value US$400.00 | Price 0.80 | Shares 500
Buy 9 Nov 2012
Value US$9,120.00 | Price 0.80 | Shares 11,400
Buy 9 Nov 2012
Value US$80.00 | Price 0.80 | Shares 100
Buy 9 Aug 2010
Value US$22,308.80 | Price 1.91 | Shares 11,680
Buy 9 Aug 2010
Value US$12,617.00 | Price 1.85 | Shares 6,820
Buy 10 Jun 2010
Value US$6,012.82 | Price 1.99 | Shares 3,020
Buy 7 Jun 2010
Value US$6,222.75 | Price 2.02 | Shares 3,076
Sale 10 Mar 2010
Value US$47,343.00 | Price 3.16 | Shares 15,000
Buy 9 Dec 2009
Value US$3,326.40 | Price 1.76 | Shares 1,890
Buy 9 Dec 2009
Value US$6,177.30 | Price 1.77 | Shares 3,490
Buy 9 Dec 2009
Value US$35.80 | Price 1.79 | Shares 20
Buy 9 Dec 2009
Value US$26,280.00 | Price 1.80 | Shares 14,600
Buy 11 Nov 2009
Value US$3,299.80 | Price 1.65 | Shares 2,000
Buy 11 Nov 2009
Value US$3,299.80 | Price 1.65 | Shares 2,000
Buy 10 Nov 2009
Value US$3,059.82 | Price 1.70 | Shares 1,800
Buy 10 Nov 2009
Value US$340.00 | Price 1.70 | Shares 200
Buy 10 Nov 2009
Value US$1,529.91 | Price 1.70 | Shares 900
Buy 10 Nov 2009
Value US$3,059.82 | Price 1.70 | Shares 1,800
Buy 10 Nov 2009
Value US$510.00 | Price 1.70 | Shares 300
Buy 10 Nov 2009
Value US$3,400.00 | Price 1.70 | Shares 2,000
Buy 10 Nov 2009
Value US$3,339.80 | Price 1.67 | Shares 2,000
Sale 10 Sep 2009
Value US$11,550.00 | Price 2.75 | Shares 4,200
Sale 10 Sep 2009
Value US$57,578.56 | Price 2.77 | Shares 20,800
Buy 12 Aug 2009
Value US$6,764.67 | Price 2.05 | Shares 3,300
Buy 12 Aug 2009
Value US$1,020.00 | Price 2.04 | Shares 500
Buy 12 Aug 2009
Value US$1,414.00 | Price 2.02 | Shares 700
Buy 12 Aug 2009
Value US$1,000.00 | Price 2.00 | Shares 500
Sale 10 Aug 2009
Value US$325,396.50 | Price 1.97 | Shares 165,000
Sale 10 Aug 2009
Value US$332,880.00 | Price 2.22 | Shares 150,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-03 2025-01-03 PrS Proposed sale
Gottfurcht Grant

10% Stockholder

Large shareholder
46,799
163.36
US$802,259 		46,799 163.36 US$802,259
2025-01-03 2025-01-02 PrS Proposed sale
Gottfurcht Grant

10% Stockholder

Large shareholder
78,129
354.57
US$464,986 		78,129 354.57 US$464,986
2025-01-02 2025-01-02 PrS Proposed sale
Gottfurcht Grant

Open Market
13,398
454.08
US$3,326,821 		13,398 454.08 US$3,326,821
2025-01-03 2024-12-31 PrS Proposed sale
Gottfurcht Grant

10% Stockholder

Large shareholder
17,806
2.73
US$48,562 		17,806 2.73 US$48,562
2025-01-02 2024-12-31 PrS Proposed sale
Gottfurcht Grant

Open Market Purchase
17,806
2.73
US$48,562 		17,806 2.73 US$48,562
2024-12-26 2024-08-09 PrS Proposed sale
Gottfurcht Grant

10% Stockholder

Large shareholder
221,375
0.26
US$56,457 		221,375 0.26 US$56,457
2018-03-14 2018-03-13 B Purchase Miller Robert E

Chief Financial Officer
1,200 +6.8%
4.10
US$4,920 		1,200 +6.8% 4.10 US$4,920
2018-03-14 2018-03-12 B Purchase Miller Robert E

Chief Financial Officer
1,200 +7.3%
4.03
US$4,836 		1,200 +7.3% 4.03 US$4,836
2018-03-13 2018-03-12 B Purchase Miller Robert E

Chief Financial Officer
1,200 +7.9%
4.03
US$4,836 		1,200 +7.9% 4.03 US$4,836
2018-03-13 2018-03-09 B Purchase Miller Robert E

Chief Financial Officer
1,200 +8.5%
3.90
US$4,680 		1,200 +8.5% 3.90 US$4,680
2018-03-08 2018-03-08 B Purchase Schutz James J

Chief Executive Officer

Executive Director
2,473 +7.4%
3.99
US$9,867 		2,473 +7.4% 3.99 US$9,867
2017-12-04 2017-11-30 B Purchase Schutz James J

Chief Executive Officer

Executive Director
345 +2.2%
4.95
US$1,708 		345 +2.2% 4.95 US$1,708
2017-11-30 2017-11-29 B Purchase Miller Robert E

Chief Financial Officer
1,290 +10.1%
5.02
US$6,476 		1,290 +10.1% 5.02 US$6,476
2017-11-30 2017-11-29 B Purchase Miller Robert E

Chief Financial Officer
500 +4.1%
5.03
US$2,515 		500 +4.1% 5.03 US$2,515
2017-11-29 2017-11-29 B Purchase Schutz James J

Chief Executive Officer

Executive Director
400 +2.6%
5.03
US$2,012 		400 +2.6% 5.03 US$2,012
2017-11-27 2017-11-24 B Purchase Schutz James J

Chief Executive Officer

Executive Director
254 +1.7%
5.05
US$1,283 		254 +1.7% 5.05 US$1,283
2017-11-24 2017-11-21 B Purchase Miller Robert E

Chief Financial Officer
500 +4.2%
5.04
US$2,520 		500 +4.2% 5.04 US$2,520
2017-11-24 2017-11-21 B Purchase Miller Robert E

Chief Financial Officer
1,500 +14.6%
5.03
US$7,545 		1,500 +14.6% 5.03 US$7,545
2017-08-14 2017-08-10 B Purchase Miller Robert E

Chief Financial Officer
2,264 +26.7%
5.30
US$11,999 		2,264 +26.7% 5.30 US$11,999
2017-08-11 2017-08-10 B Purchase Umscheid Marc

Chief Strategy/Mkt Officer
600 +21.5%
5.31
US$3,186 		600 +21.5% 5.31 US$3,186
2017-08-10 2017-08-10 B Purchase Schutz James J

Chief Executive Officer

Executive Director
929 +6.5%
5.46
US$5,069 		929 +6.5% 5.46 US$5,069
2017-03-13 2017-03-09 B Purchase Miller Robert E

Chief Financial Officer
250 +3.0%
7.14
US$1,785 		250 +3.0% 7.14 US$1,785
2017-03-13 2017-03-09 B Purchase Miller Robert E

Chief Financial Officer
250 +3.1%
6.96
US$1,740 		250 +3.1% 6.96 US$1,740
2017-03-13 2017-03-09 B Purchase Miller Robert E

Chief Financial Officer
250 +3.2%
6.97
US$1,742 		250 +3.2% 6.97 US$1,742
2017-03-09 2017-03-08 B Purchase Miller Robert E

Chief Financial Officer
750 +10.8%
6.97
US$5,228 		750 +10.8% 6.97 US$5,228
2017-03-09 2017-03-08 B Purchase Miller Robert E

Chief Financial Officer
250 +3.7%
6.81
US$1,702 		250 +3.7% 6.81 US$1,702
2017-03-08 2017-03-06 B Purchase Umscheid Marc

Chief Strategy/Mkt Officer
750 +inf%
6.82
US$5,115 		750 +inf% 6.82 US$5,115
2017-03-07 2017-03-03 B Purchase Schutz James J

Chief Executive Officer

Executive Director
104 +0.9%
6.75
US$702 		104 +0.9% 6.75 US$702
2017-03-07 2017-03-03 B Purchase Schutz James J

Chief Executive Officer

Executive Director
696 +6.3%
6.78
US$4,719 		696 +6.3% 6.78 US$4,719
2016-12-12 2016-12-08 B Purchase Miller Robert E

Chief Financial Officer

Officer
5,000 +291.7%
4.86
US$24,300 		5,000 +291.7% 4.86 US$24,300
2016-12-08 2016-12-08 B Purchase Schutz James J

Chief Executive Officer

Executive Director
1,000 +10.0%
4.88
US$4,880 		1,000 +10.0% 4.88 US$4,880
2016-08-16 2016-08-15 B Purchase Schutz James J

Chief Executive Officer

Executive Director
1,328 +25.7%
3.66
US$4,866 		1,328 +25.7% 3.66 US$4,866
2016-02-29 2016-02-25 B Purchase Schutz James J

Chief Executive Officer

Executive Director
5,000 +23.9%
1.00
US$5,000 		5,000 +23.9% 1.00 US$5,000
2014-11-17 2014-11-17 B Purchase Schutz James J

Chief Executive Officer

Executive Director
6,285 +43.0%
1.78
US$11,187 		6,285 +43.0% 1.78 US$11,187
2013-08-19 2013-08-16 B Purchase Schutz James J

Chief Executive Officer

Executive Director
5,100 +53.7%
2.35
US$11,985 		5,100 +53.7% 2.35 US$11,985
2012-12-10 2012-12-10 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
2,500 +0.2%
0.64
US$1,598 		2,500 +0.2% 0.64 US$1,598
2012-12-10 2012-12-10 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
3,000 +0.3%
0.64
US$1,909 		3,000 +0.3% 0.64 US$1,909
2012-12-11 2012-12-07 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
100 +0.0%
0.65
US$65 		100 +0.0% 0.65 US$65
2012-12-11 2012-12-07 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
2,200 +0.2%
0.65
US$1,428 		2,200 +0.2% 0.65 US$1,428
2012-12-11 2012-12-07 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
2,000 +0.2%
0.65
US$1,295 		2,000 +0.2% 0.65 US$1,295
2012-12-11 2012-12-07 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
1,000 +0.1%
0.65
US$650 		1,000 +0.1% 0.65 US$650
2012-12-07 2012-12-06 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
4,000 +0.4%
0.64
US$2,549 		4,000 +0.4% 0.64 US$2,549
2012-12-07 2012-12-06 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
3,000 +0.3%
0.63
US$1,899 		3,000 +0.3% 0.63 US$1,899
2012-12-07 2012-12-06 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
1,000 +0.1%
0.63
US$629 		1,000 +0.1% 0.63 US$629
2012-12-07 2012-12-06 B Purchase Alimi Hojabr

Chief Executive Officer

Executive Director
1,000 +0.1%
0.63
US$626 		1,000 +0.1% 0.63 US$626
2012-11-09 2012-11-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
1,000 +1.5%
0.78
US$780 		1,000 +1.5% 0.78 US$780
2012-11-09 2012-11-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
500 +0.8%
0.80
US$400 		500 +0.8% 0.80 US$400
2012-11-09 2012-11-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
11,400 +21.3%
0.80
US$9,120 		11,400 +21.3% 0.80 US$9,120
2012-11-09 2012-11-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
100 +0.2%
0.80
US$80 		100 +0.2% 0.80 US$80
2010-08-09 2010-08-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
11,680 +27.9%
1.91
US$22,309 		11,680 +27.9% 1.91 US$22,309
2010-08-09 2010-08-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
6,820 +19.5%
1.85
US$12,617 		6,820 +19.5% 1.85 US$12,617
2010-06-10 2010-06-10 B Purchase French Gregory M

Chief Operating Officer

Executive Director
3,020 +6.1%
1.99
US$6,013 		3,020 +6.1% 1.99 US$6,013
2010-06-09 2010-06-07 B Purchase French Gregory M

Chief Operating Officer

Executive Director
3,076 +6.6%
2.02
US$6,223 		3,076 +6.6% 2.02 US$6,223
2010-03-11 2010-03-10 S Sale Alimi Hojabr

Chief Executive Officer

Executive Director
15,000 -1.5%
3.16
US$47,343 		15,000 -1.5% 3.16 US$47,343
2009-12-09 2009-12-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
1,890 +5.7%
1.76
US$3,326 		1,890 +5.7% 1.76 US$3,326
2009-12-09 2009-12-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
3,490 +11.8%
1.77
US$6,177 		3,490 +11.8% 1.77 US$6,177
2009-12-09 2009-12-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
20 +0.1%
1.79
US$36 		20 +0.1% 1.79 US$36
2009-12-09 2009-12-09 B Purchase Schutz James J

Chief Operating Officer

Executive Director
14,600 +97.3%
1.80
US$26,280 		14,600 +97.3% 1.80 US$26,280
2009-11-12 2009-11-11 B Purchase Miller Robert E

Chief Financial Officer

Officer
2,000 +2.8%
1.65
US$3,300 		2,000 +2.8% 1.65 US$3,300
2009-11-12 2009-11-11 B Purchase Miller Robert E

Chief Financial Officer

Officer
2,000 +2.9%
1.65
US$3,300 		2,000 +2.9% 1.65 US$3,300
2009-11-12 2009-11-10 B Purchase Miller Robert E

Chief Financial Officer

Officer
1,800 +2.7%
1.70
US$3,060 		1,800 +2.7% 1.70 US$3,060
2009-11-12 2009-11-10 B Purchase Miller Robert E

Chief Financial Officer

Officer
200 +0.3%
1.70
US$340 		200 +0.3% 1.70 US$340
2009-11-12 2009-11-10 B Purchase Miller Robert E

Chief Financial Officer

Officer
900 +1.4%
1.70
US$1,530 		900 +1.4% 1.70 US$1,530
2009-11-12 2009-11-10 B Purchase Miller Robert E

Chief Financial Officer

Officer
1,800 +2.8%
1.70
US$3,060 		1,800 +2.8% 1.70 US$3,060
2009-11-12 2009-11-10 B Purchase Miller Robert E

Chief Financial Officer

Officer
300 +0.5%
1.70
US$510 		300 +0.5% 1.70 US$510
2009-11-12 2009-11-10 B Purchase Miller Robert E

Chief Financial Officer

Officer
2,000 +3.2%
1.70
US$3,400 		2,000 +3.2% 1.70 US$3,400
2009-11-12 2009-11-10 B Purchase Miller Robert E

Chief Financial Officer

Officer
2,000 +3.3%
1.67
US$3,340 		2,000 +3.3% 1.67 US$3,340
2009-09-10 2009-09-10 S Sale Conley Richard K Non-Executive Director
4,200 -3.8%
2.75
US$11,550 		4,200 -3.8% 2.75 US$11,550
2009-09-10 2009-09-10 S Sale Conley Richard K Non-Executive Director
20,800 -15.7%
2.77
US$57,579 		20,800 -15.7% 2.77 US$57,579
2009-08-13 2009-08-12 B Purchase Schutz James J

Vice President

Executive Director
3,300 +28.2%
2.05
US$6,765 		3,300 +28.2% 2.05 US$6,765
2009-08-13 2009-08-12 B Purchase Schutz James J

Vice President

Executive Director
500 +4.5%
2.04
US$1,020 		500 +4.5% 2.04 US$1,020
2009-08-13 2009-08-12 B Purchase Schutz James J

Vice President

Executive Director
700 +6.7%
2.02
US$1,414 		700 +6.7% 2.02 US$1,414
2009-08-13 2009-08-12 B Purchase Schutz James J

Vice President

Executive Director
500 +5.0%
2.00
US$1,000 		500 +5.0% 2.00 US$1,000
2009-08-12 2009-08-10 S Sale Alimi Hojabr

Chief Executive Officer

Executive Director
165,000 -14.0%
1.97
US$325,396 		165,000 -14.0% 1.97 US$325,396
2009-08-12 2009-08-10 S Sale Alimi Hojabr

Chief Executive Officer

Executive Director
150,000 -11.3%
2.22
US$332,880 		150,000 -11.3% 2.22 US$332,880
Explore more

More insider trading research around Sonoma Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America